Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last 21.70 NOK
Change Today 0.00 / 0.00%
Volume 0.0
NANO On Other Exchanges
Symbol
Exchange
Frankfurt
As of 10:25 AM 09/1/15 All times are local (Market data is delayed by at least 15 minutes).

nordic nanovector asa (NANO) Snapshot

Open
22.40 NOK
Previous Close
21.70 NOK
Day High
22.90 NOK
Day Low
21.40 NOK
52 Week High
01/28/15 - 39.00 NOK
52 Week Low
08/26/15 - 19.40 NOK
Market Cap
915.2M
Average Volume 10 Days
164.2K
EPS TTM
-3.74 NOK
Shares Outstanding
42.2M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for NORDIC NANOVECTOR ASA (NANO)

Related News

No related news articles were found.

nordic nanovector asa (NANO) Related Businessweek News

No Related Businessweek News Found

nordic nanovector asa (NANO) Details

Nordic Nanovector ASA, a biotech company, develops, manufactures, and delivers antibody-radionuclide-conjugate (ARC) clinical solutions to address unmet medical needs and advance cancer care in patients. Its lead product candidate is Betalutin, an ARC that is in Phase I/II clinical trial for the treatment of patients with non-hodgkin lymphoma, a life-threatening blood cancer. The company was formerly known as Nordic Nanovector AS and changed its name to Nordic Nanovector ASA in 2014. Nordic Nanovector ASA was founded in 2009 and is headquartered in Oslo, Norway.

28 Employees
Last Reported Date: 08/26/15
Founded in 2009

nordic nanovector asa (NANO) Top Compensated Officers

Chief Executive Officer
Total Annual Compensation: 907.3K NOK
Chief Financial Officer
Total Annual Compensation: 1.1M NOK
Chief Operations Officer
Total Annual Compensation: 1.3M NOK
Chief Quality Officer
Total Annual Compensation: 868.1K NOK
Chief Clinical Officer
Total Annual Compensation: 741.2K NOK
Compensation as of Fiscal Year 2014.

nordic nanovector asa (NANO) Key Developments

Nordic Nanovector AS Announces Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended June 30, 2015

Nordic Nanovector AS announced unaudited consolidated earnings results for the second quarter and six months ended June 30, 2015. For the quarter, the company reported total operating revenue was NOK 141,961 against NOK 118,461 a year ago. Operating loss was NOK 51,064,152 against NOK 15,714,697 a year ago. Loss before income tax was NOK 47,632,770 against NOK 15,218,663 a year ago. Loss for the period attributable to the owners of the company was NOK 47,722,074 or NOK 1.09 per basic and dilute share against NOK 15,218,663 or NOK 1.32 per basic and dilute share a year ago. For the six months, the company reported total operating revenue was NOK 218,002 against NOK 236,604 a year ago. Operating loss was NOK 86,887,207 against NOK 27,606,260 a year ago. Loss before income tax was NOK 81,367,400 against NOK 26,566,019 a year ago. Loss for the period attributable to the owners of the company was NOK 81,407,153 or NOK 2.24 per basic and dilute share against NOK 26,566,019 or NOK 2.34 per basic and dilute share a year ago. Net cash used in operating activities was NOK 65,829,711 against NOK 28,012,439 a year ago.

Nordic Nanovector ASA Reports Revenue Results for the Second Quarter and Six Months Ended June 30, 2015

Nordic Nanovector ASA reported revenue results for the second quarter and six months ended June 30, 2015. For the quarter, the company reported revenues for the second quarter 2015 amounted to NOK 141,961 against NOK 118,143 a year ago. For the six months, the company reported revenues for the first half 2015 were NOK 218,002 against NOK 236,604 a year ago.

Nordic Nanovector ASA Presents at Pareto Securities 6th Annual Health Care Seminar, Aug-28-2015 10:30 AM

Nordic Nanovector ASA Presents at Pareto Securities 6th Annual Health Care Seminar, Aug-28-2015 10:30 AM. Venue: Stockholm, Sweden. Speakers: Luigi Costa, Chief Executive Officer.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
NANO:NO 21.70 NOK 0.00

NANO Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for NANO.
View Industry Companies
 

Industry Analysis

NANO

Industry Average

Valuation NANO Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 3,542.7x
Price/Book 1.9x
Price/Cash Flow -- Not Meaningful
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact NORDIC NANOVECTOR ASA, please visit www.nordicnanovector.no. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.